New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells

Detalhes bibliográficos
Autor(a) principal: França, Monica Malheiros
Data de Publicação: 2017
Outros Autores: Lerario, Antonio M., Fragoso, Maria Candida B.V., Lotfi, Claudimara Ferini Pacicco
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
DOI: 10.6061/clinics/2017(06)10
Texto Completo: https://www.revistas.usp.br/clinics/article/view/134126
Resumo: OBJECTIVES: Transcription Factor 21 represses steroidogenic factor 1, a nuclear receptor required for gonadal development, sex determination and the regulation of adrenogonadal steroidogenesis. The aim of this study was to investigate whether silencing or overexpression of the gene Transcription Factor 21 could modulate the gene and protein expression of steroidogenic factor 1 in adrenocortical tumors. METHODS: We analyzed the gene expression of steroidogenic factor 1 using qPCR after silencing endogenous Transcription Factor 21 in pediatric adrenal adenoma-T7 cells through small interfering RNA. In addition, using overexpression of Transcription Factor 21 in human adrenocortical carcinoma cells, we analyzed the protein expression of steroidogenic factor 1 using Western blotting. RESULTS: Transcription Factor 21 knockdown increased the mRNA expression of steroidogenic factor 1 by 5.97-fold in pediatric adrenal adenoma-T7 cells. Additionally, Transcription Factor 21 overexpression inhibited the protein expression of steroidogenic factor 1 by 0.41-fold and 0.64-fold in two different adult adrenocortical carcinoma cell cultures, H295R and T36, respectively. CONCLUSIONS: Transcription Factor 21 is downregulated in adrenocortical carcinoma cells. Taken together, these findings support the hypothesis that Transcription Factor 21 is a regulator of steroidogenic factor 1 and is a tumor suppressor gene in pediatric and adult adrenocortical tumors.
id USP-19_b2bd566a450f1ae54005dfc5576366e9
oai_identifier_str oai:revistas.usp.br:article/134126
network_acronym_str USP-19
network_name_str Clinics
spelling New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cellsTCF21POD1SF-1siRNA-POD1Adrenocortical Tumor CellsOBJECTIVES: Transcription Factor 21 represses steroidogenic factor 1, a nuclear receptor required for gonadal development, sex determination and the regulation of adrenogonadal steroidogenesis. The aim of this study was to investigate whether silencing or overexpression of the gene Transcription Factor 21 could modulate the gene and protein expression of steroidogenic factor 1 in adrenocortical tumors. METHODS: We analyzed the gene expression of steroidogenic factor 1 using qPCR after silencing endogenous Transcription Factor 21 in pediatric adrenal adenoma-T7 cells through small interfering RNA. In addition, using overexpression of Transcription Factor 21 in human adrenocortical carcinoma cells, we analyzed the protein expression of steroidogenic factor 1 using Western blotting. RESULTS: Transcription Factor 21 knockdown increased the mRNA expression of steroidogenic factor 1 by 5.97-fold in pediatric adrenal adenoma-T7 cells. Additionally, Transcription Factor 21 overexpression inhibited the protein expression of steroidogenic factor 1 by 0.41-fold and 0.64-fold in two different adult adrenocortical carcinoma cell cultures, H295R and T36, respectively. CONCLUSIONS: Transcription Factor 21 is downregulated in adrenocortical carcinoma cells. Taken together, these findings support the hypothesis that Transcription Factor 21 is a regulator of steroidogenic factor 1 and is a tumor suppressor gene in pediatric and adult adrenocortical tumors.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2017-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/13412610.6061/clinics/2017(06)10Clinics; Vol. 72 No. 6 (2017); 391-394Clinics; v. 72 n. 6 (2017); 391-394Clinics; Vol. 72 Núm. 6 (2017); 391-3941980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/134126/129937Copyright (c) 2017 Clinicsinfo:eu-repo/semantics/openAccessFrança, Monica MalheirosLerario, Antonio M.Fragoso, Maria Candida B.V.Lotfi, Claudimara Ferini Pacicco2017-06-29T12:15:35Zoai:revistas.usp.br:article/134126Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2017-06-29T12:15:35Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells
title New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells
spellingShingle New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells
New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells
França, Monica Malheiros
TCF21
POD1
SF-1
siRNA-POD1
Adrenocortical Tumor Cells
França, Monica Malheiros
TCF21
POD1
SF-1
siRNA-POD1
Adrenocortical Tumor Cells
title_short New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells
title_full New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells
title_fullStr New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells
New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells
title_full_unstemmed New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells
New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells
title_sort New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells
author França, Monica Malheiros
author_facet França, Monica Malheiros
França, Monica Malheiros
Lerario, Antonio M.
Fragoso, Maria Candida B.V.
Lotfi, Claudimara Ferini Pacicco
Lerario, Antonio M.
Fragoso, Maria Candida B.V.
Lotfi, Claudimara Ferini Pacicco
author_role author
author2 Lerario, Antonio M.
Fragoso, Maria Candida B.V.
Lotfi, Claudimara Ferini Pacicco
author2_role author
author
author
dc.contributor.author.fl_str_mv França, Monica Malheiros
Lerario, Antonio M.
Fragoso, Maria Candida B.V.
Lotfi, Claudimara Ferini Pacicco
dc.subject.por.fl_str_mv TCF21
POD1
SF-1
siRNA-POD1
Adrenocortical Tumor Cells
topic TCF21
POD1
SF-1
siRNA-POD1
Adrenocortical Tumor Cells
description OBJECTIVES: Transcription Factor 21 represses steroidogenic factor 1, a nuclear receptor required for gonadal development, sex determination and the regulation of adrenogonadal steroidogenesis. The aim of this study was to investigate whether silencing or overexpression of the gene Transcription Factor 21 could modulate the gene and protein expression of steroidogenic factor 1 in adrenocortical tumors. METHODS: We analyzed the gene expression of steroidogenic factor 1 using qPCR after silencing endogenous Transcription Factor 21 in pediatric adrenal adenoma-T7 cells through small interfering RNA. In addition, using overexpression of Transcription Factor 21 in human adrenocortical carcinoma cells, we analyzed the protein expression of steroidogenic factor 1 using Western blotting. RESULTS: Transcription Factor 21 knockdown increased the mRNA expression of steroidogenic factor 1 by 5.97-fold in pediatric adrenal adenoma-T7 cells. Additionally, Transcription Factor 21 overexpression inhibited the protein expression of steroidogenic factor 1 by 0.41-fold and 0.64-fold in two different adult adrenocortical carcinoma cell cultures, H295R and T36, respectively. CONCLUSIONS: Transcription Factor 21 is downregulated in adrenocortical carcinoma cells. Taken together, these findings support the hypothesis that Transcription Factor 21 is a regulator of steroidogenic factor 1 and is a tumor suppressor gene in pediatric and adult adrenocortical tumors.
publishDate 2017
dc.date.none.fl_str_mv 2017-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/134126
10.6061/clinics/2017(06)10
url https://www.revistas.usp.br/clinics/article/view/134126
identifier_str_mv 10.6061/clinics/2017(06)10
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/134126/129937
dc.rights.driver.fl_str_mv Copyright (c) 2017 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2017 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 72 No. 6 (2017); 391-394
Clinics; v. 72 n. 6 (2017); 391-394
Clinics; Vol. 72 Núm. 6 (2017); 391-394
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1822181677751861248
dc.identifier.doi.none.fl_str_mv 10.6061/clinics/2017(06)10